Literature DB >> 3584073

Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes.

B Aricò, R Rappuoli.   

Abstract

Pertussis toxin, the major virulence factor of Bordetella pertussis, is not produced by the closely related species Bordetella parapertussis and Bordetella bronchiseptica. It is shown here that these two species possess but do not express the complete toxin operon. Nucleotide sequencing of an EcoRI fragment of 5 kilobases comprising the regions homologous to the pertussis toxin genes shows that in this region, B. parapertussis and B. bronchiseptica are 98.5% and 96% homologous, respectively, to B. pertussis. The changes (mostly base pair substitutions) in many cases are identical in B. parapertussis and B. bronchiseptica, suggesting that these two species derive from a common ancestor. Many of the mutations common to B. parapertussis and B. bronchiseptica involve the promoter region, which becomes very inefficient. The S1 subunits of both species, when expressed in Escherichia coli, have the same ADP-ribosylating activity as the S1 subunit from B. pertussis, indicating that the mutations in the S1 gene described here do not affect its function.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3584073      PMCID: PMC212198          DOI: 10.1128/jb.169.6.2847-2853.1987

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  25 in total

1.  Conversion of Bordetella pertussis to Bordetella parapertussis.

Authors:  N H Kumazawa; M Yoshikawa
Journal:  J Hyg (Lond)       Date:  1978-08

2.  Epidemics of parapertussis. 20 years' observations in Denmark.

Authors:  H Lautrop
Journal:  Lancet       Date:  1971-06-12       Impact factor: 79.321

3.  Parapertussis: an abortive pertussis infection?

Authors:  M Granström; P Askelöf
Journal:  Lancet       Date:  1982-12-04       Impact factor: 79.321

4.  Plasmid vectors for high-efficiency expression controlled by the PL promoter of coliphage lambda.

Authors:  E Remaut; P Stanssens; W Fiers
Journal:  Gene       Date:  1981-10       Impact factor: 3.688

5.  pEMBL: a new family of single stranded plasmids.

Authors:  L Dente; G Cesareni; R Cortese
Journal:  Nucleic Acids Res       Date:  1983-03-25       Impact factor: 16.971

6.  Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin.

Authors:  E L Hewlett; K T Sauer; G A Myers; J L Cowell; R L Guerrant
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

7.  Sequence determinants of promoter activity.

Authors:  P Youderian; S Bouvier; M M Susskind
Journal:  Cell       Date:  1982-10       Impact factor: 41.582

8.  Bordetella parapertussis. Recent experience and a review of the literature.

Authors:  C C Linnemann; E B Perry
Journal:  Am J Dis Child       Date:  1977-05

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Effect of heptakis (2,6-O-dimethyl) beta-cyclodextrin on the production of pertussis toxin by Bordetella pertussis.

Authors:  A Imaizumi; Y Suzuki; S Ono; H Sato; Y Sato
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

View more
  80 in total

1.  Use of pertussis toxin encoded by ptx genes from Bordetella bronchiseptica to model the effects of antigenic drift of pertussis toxin on antibody neutralization.

Authors:  S Z Hausman; D L Burns
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

2.  Derivation of a physical map of the chromosome of Bordetella pertussis Tohama I.

Authors:  S Stibitz; T L Garletts
Journal:  J Bacteriol       Date:  1992-12       Impact factor: 3.490

Review 3.  Cyclic AMP in prokaryotes.

Authors:  J L Botsford; J G Harman
Journal:  Microbiol Rev       Date:  1992-03

4.  Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein.

Authors:  Nicholas H Carbonetti; Galina V Artamonova; Charlotte Andreasen; Edward Dudley; R Michael Mays; Zoe E V Worthington
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

5.  Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States.

Authors:  Andrew L Baughman; Kristine M Bisgard; Kathryn M Edwards; Dalya Guris; Michael D Decker; Kathy Holland; Bruce D Meade; Freyja Lynn
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

Review 6.  Bordetella pertussis: the intersection of genomics and pathobiology.

Authors:  Andrew Preston
Journal:  CMAJ       Date:  2005-07-05       Impact factor: 8.262

7.  Bordetella pertussis risA, but not risS, is required for maximal expression of Bvg-repressed genes.

Authors:  Trevor H Stenson; Andrew G Allen; Jehan A Al-Meer; Duncan Maskell; Mark S Peppler
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

8.  Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis.

Authors:  Xuqing Zhang; Sara E Hester; Mary J Kennett; Alexia T Karanikas; Liron Bendor; David E Place; Eric T Harvill
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

9.  BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model.

Authors:  P A Cotter; J F Miller
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

10.  bvg Repression of alcaligin synthesis in Bordetella bronchiseptica is associated with phylogenetic lineage.

Authors:  P C Giardina; L A Foster; J M Musser; B J Akerley; J F Miller; D W Dyer
Journal:  J Bacteriol       Date:  1995-11       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.